Benefits of the next comparative review had been documented by Flinn et al. It is a stage III randomized Intergroup trial comparing FC regimen as opposed to FAMP by itself in 278 patients getting their very first chemotherapy program for B-CLL. Dosages of FC program had been similar to the https://tranilast22109.blogdigy.com/pentagalloylglucose-for-dummies-44831634